AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Cardiology Clinical Pearls and Therapies
This chapter explores clinical pearls in cardiology, focusing on HEFF PEP guidelines and therapies, with a spotlight on SGLT2 inhibitors as upfront therapy. Discussions include upcoming 2024 guidelines and the use of apo B versus LDL cholesterol in lipid panels. The conversation delves into risk stratification methods, challenges in interpreting ferritin levels, and the impact of IV ferricmoxetol on MRI diagnostic accuracy.